Arm Morbidity After Local Therapy for Young Breast Cancer Patients

[1]  K. Schmitz,et al.  Drivers of cost differences between US breast cancer survivors with or without lymphedema , 2019, Journal of Cancer Survivorship.

[2]  W. Shi,et al.  Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis , 2018, Cancer.

[3]  R. Jagsi,et al.  Impact of Radiotherapy on Complications and Patient-Reported Outcomes After Breast Reconstruction , 2018, Journal of the National Cancer Institute.

[4]  M. Mazumdar,et al.  Postmastectomy Radiation in Breast Cancer Patients With Pathologically Positive Lymph Nodes After Neoadjuvant Chemotherapy: Usage Rates and Survival Trends. , 2017, International journal of radiation oncology, biology, physics.

[5]  T. King,et al.  Age, molecular subtypes and local therapy decision-making. , 2017, Breast.

[6]  A. Jemal,et al.  State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012 , 2017, JAMA surgery.

[7]  R. Tamimi,et al.  BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer. , 2016, JAMA oncology.

[8]  Jama Oncology.  BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer , 2016 .

[9]  R. Mansel,et al.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. , 2014, The Lancet. Oncology.

[10]  C. Beurskens,et al.  Treatment Related Impairments in Arm and Shoulder in Patients with Breast Cancer: A Systematic Review , 2014, PloS one.

[11]  B. Newman,et al.  Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. , 2013, The Lancet. Oncology.

[12]  K. Schmitz,et al.  Upper‐body morbidity after breast cancer , 2012, Cancer.

[13]  A. Di Spiezio Sardo,et al.  Quality of life, lifestyle behavior and employment experience: a comparison between young and midlife survivors of gynecology early stage cancers. , 2012, Gynecologic oncology.

[14]  A. Giuliano,et al.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.

[15]  T. Julian,et al.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. , 2010, The Lancet. Oncology.

[16]  B. Rimer,et al.  Longitudinal Predictors of Nonadherence to Maintenance of Mammography , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[17]  A. Bleyer,et al.  Cancer in young adults 20 to 39 years of age: overview. , 2009, Seminars in oncology.

[18]  U. Chetty,et al.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.

[19]  P. Ganz,et al.  The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. , 2005, Journal of the National Cancer Institute.

[20]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[21]  A. Cheville,et al.  The grading of lymphedema in oncology clinical trials. , 2003, Seminars in radiation oncology.

[22]  M A Hlatky,et al.  Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. , 1992, JAMA.

[23]  B Fisher,et al.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. , 1985, The New England journal of medicine.